Oil & Gas Drilling
Compare Stocks
5 / 10Stock Comparison
HP vs XOM vs CVX vs OXY vs DVN
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Oil & Gas Exploration & Production
Oil & Gas Exploration & Production
HP vs XOM vs CVX vs OXY vs DVN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Drilling | Oil & Gas Integrated | Oil & Gas Integrated | Oil & Gas Exploration & Production | Oil & Gas Exploration & Production |
| Market Cap | $3.68B | $620.85B | $364.18B | $53.66B | $28.19B |
| Revenue (TTM) | $4.00B | $323.90B | $184.43B | $23.18B | $12.24B |
| Net Income (TTM) | $-376M | $28.84B | $12.30B | $4.71B | $2.15B |
| Gross Margin | 11.3% | 21.7% | 30.4% | 26.2% | 21.8% |
| Operating Margin | -1.8% | 10.5% | 9.0% | 12.4% | 18.9% |
| Forward P/E | — | 14.8x | 15.0x | 13.0x | 8.6x |
| Total Debt | $2.32B | $43.54B | $46.74B | $23.96B | $8.78B |
| Cash & Equiv. | $224M | $10.68B | $6.47B | $1.99B | $1.43B |
HP vs XOM vs CVX vs OXY vs DVN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Helmerich & Payne, … (HP) | 100 | 183.3 | +83.3% |
| Exxon Mobil Corpora… (XOM) | 100 | 322.2 | +222.2% |
| Chevron Corporation (CVX) | 100 | 199.0 | +99.0% |
| Occidental Petroleu… (OXY) | 100 | 416.6 | +316.6% |
| Devon Energy Corpor… (DVN) | 100 | 419.6 | +319.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HP vs XOM vs CVX vs OXY vs DVN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HP is the #2 pick in this set and the best alternative if defensive is your priority.
- Beta 0.87, yield 2.8%, current ratio 1.80x
- 35.9% revenue growth vs OXY's -20.3%
- +99.5% vs CVX's +39.5%
XOM is the clearest fit if your priority is long-term compounding.
- 105.0% 10Y total return vs CVX's 135.8%
CVX ranks third and is worth considering specifically for income & stability.
- Dividend streak 8 yrs, beta -0.05, yield 3.8%
- 3.8% yield, 8-year raise streak, vs XOM's 2.7%
OXY is the clearest fit if your priority is quality.
- 20.3% margin vs HP's -9.4%
DVN carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 10.0%, EPS growth -8.1%, 3Y rev CAGR -4.8%
- Lower volatility, beta 0.05, Low D/E 56.6%, current ratio 0.98x
- Lower P/E (8.6x vs 13.0x)
- Beta 0.05 vs HP's 0.87, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.9% revenue growth vs OXY's -20.3% | |
| Value | Lower P/E (8.6x vs 13.0x) | |
| Quality / Margins | 20.3% margin vs HP's -9.4% | |
| Stability / Safety | Beta 0.05 vs HP's 0.87, lower leverage | |
| Dividends | 3.8% yield, 8-year raise streak, vs XOM's 2.7% | |
| Momentum (1Y) | +99.5% vs CVX's +39.5% | |
| Efficiency (ROA) | 9.1% ROA vs HP's -5.7%, ROIC 12.3% vs 3.7% |
HP vs XOM vs CVX vs OXY vs DVN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HP vs XOM vs CVX vs OXY vs DVN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
DVN leads in 1 of 6 categories
XOM leads 1 • HP leads 0 • CVX leads 0 • OXY leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — OXY and DVN each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 80.9x HP's $4.0B. OXY is the more profitable business, keeping 20.3% of every revenue dollar as net income compared to HP's -9.4%. On growth, XOM holds the edge at -1.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.0B | $323.9B | $184.4B | $23.2B | $12.2B |
| EBITDAEarnings before interest/tax | $657M | $59.9B | $37.1B | $10.6B | $5.0B |
| Net IncomeAfter-tax profit | -$376M | $28.8B | $12.3B | $4.7B | $2.1B |
| Free Cash FlowCash after capex | $256M | $23.6B | $16.2B | $3.6B | $2.1B |
| Gross MarginGross profit ÷ Revenue | +11.3% | +21.7% | +30.4% | +26.2% | +21.8% |
| Operating MarginEBIT ÷ Revenue | -1.8% | +10.5% | +9.0% | +12.4% | +18.9% |
| Net MarginNet income ÷ Revenue | -9.4% | +8.9% | +6.7% | +20.3% | +17.6% |
| FCF MarginFCF ÷ Revenue | +6.4% | +7.3% | +8.8% | +15.4% | +16.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.2% | -1.3% | -5.3% | -23.1% | -99.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -47.8% | -11.0% | -24.5% | +3.1% | -100.0% |
Valuation Metrics
Evenly matched — HP and DVN each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 10.8x trailing earnings, DVN trades at a 68% valuation discount to OXY's 33.5x P/E. On an enterprise value basis, DVN's 4.8x EV/EBITDA is more attractive than XOM's 10.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.7B | $620.8B | $364.2B | $53.7B | $28.2B |
| Enterprise ValueMkt cap + debt − cash | $5.8B | $653.7B | $404.5B | $75.6B | $35.5B |
| Trailing P/EPrice ÷ TTM EPS | -22.23x | 21.86x | 27.53x | 33.51x | 10.80x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.79x | 15.02x | 12.99x | 8.62x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 6.74x | 10.91x | 10.89x | 6.66x | 4.79x |
| Price / SalesMarket cap ÷ Revenue | 0.98x | 1.92x | 1.97x | 2.49x | 1.65x |
| Price / BookPrice ÷ Book value/share | 1.29x | 2.37x | 1.76x | 1.47x | 1.84x |
| Price / FCFMarket cap ÷ FCF | 31.61x | 26.29x | 21.95x | 13.07x | 9.04x |
Profitability & Efficiency
DVN leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
DVN delivers a 18.6% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-14 for HP. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to HP's 0.82x. On the Piotroski fundamental quality scale (0–9), CVX scores 5/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -13.6% | +10.7% | +7.2% | +12.6% | +18.6% |
| ROA (TTM)Return on assets | -5.7% | +6.4% | +4.2% | +5.6% | +9.1% |
| ROICReturn on invested capital | +3.7% | +8.6% | +6.2% | +4.7% | +12.3% |
| ROCEReturn on capital employed | +4.1% | +8.9% | +6.6% | +4.9% | +13.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 3 | 5 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.82x | 0.16x | 0.24x | 0.65x | 0.57x |
| Net DebtTotal debt minus cash | $2.1B | $32.9B | $40.3B | $22.0B | $7.3B |
| Cash & Equiv.Liquid assets | $224M | $10.7B | $6.5B | $2.0B | $1.4B |
| Total DebtShort + long-term debt | $2.3B | $43.5B | $46.7B | $24.0B | $8.8B |
| Interest CoverageEBIT ÷ Interest expense | -1.92x | 69.44x | 17.22x | 3.25x | 7.98x |
Total Returns (Dividends Reinvested)
XOM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XOM five years ago would be worth $26,464 today (with dividends reinvested), compared to $14,401 for HP. Over the past 12 months, HP leads with a +99.5% total return vs CVX's +39.5%. The 3-year compound annual growth rate (CAGR) favors XOM at 13.2% vs OXY's -1.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +24.1% | +20.3% | +18.2% | +27.9% | +20.4% |
| 1-Year ReturnPast 12 months | +99.5% | +43.9% | +39.5% | +40.8% | +52.9% |
| 3-Year ReturnCumulative with dividends | +29.1% | +44.9% | +26.7% | -4.0% | -2.0% |
| 5-Year ReturnCumulative with dividends | +44.0% | +164.6% | +94.0% | +109.3% | +120.1% |
| 10-Year ReturnCumulative with dividends | -3.5% | +105.0% | +135.8% | -7.7% | +99.0% |
| CAGR (3Y)Annualised 3-year return | +8.9% | +13.2% | +8.2% | -1.4% | -0.7% |
Risk & Volatility
Evenly matched — HP and XOM each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than HP's 0.87 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HP currently trades 88.5% from its 52-week high vs OXY's 80.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.87x | -0.15x | -0.05x | -0.13x | 0.05x |
| 52-Week HighHighest price in past year | $41.68 | $176.41 | $214.71 | $67.45 | $52.71 |
| 52-Week LowLowest price in past year | $14.65 | $101.19 | $133.77 | $38.72 | $29.70 |
| % of 52W HighCurrent price vs 52-week peak | +88.5% | +83.0% | +85.0% | +80.0% | +86.0% |
| RSI (14)Momentum oscillator 0–100 | 60.7 | 42.4 | 42.1 | 41.5 | 43.5 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 18.9M | 11.0M | 17.2M | 15.3M |
Analyst Outlook
Evenly matched — XOM and CVX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: HP as "Hold", XOM as "Hold", CVX as "Buy", OXY as "Buy", DVN as "Buy". Consensus price targets imply 18.6% upside for DVN (target: $54) vs -0.1% for HP (target: $37). For income investors, CVX offers the higher dividend yield at 3.76% vs DVN's 2.17%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $36.86 | $160.43 | $190.93 | $56.64 | $53.78 |
| # AnalystsCovering analysts | 43 | 55 | 53 | 52 | 64 |
| Dividend YieldAnnual dividend ÷ price | +2.8% | +2.7% | +3.8% | +3.0% | +2.2% |
| Dividend StreakConsecutive years of raises | 0 | 26 | 8 | 4 | 0 |
| Dividend / ShareAnnual DPS | $1.01 | $4.00 | $6.87 | $1.59 | $0.98 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.3% | +3.3% | 0.0% | +3.7% |
DVN leads in 1 of 6 categories (Profitability & Efficiency). XOM leads in 1 (Total Returns). 4 tied.
HP vs XOM vs CVX vs OXY vs DVN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HP or XOM or CVX or OXY or DVN a better buy right now?
For growth investors, Helmerich & Payne, Inc.
(HP) is the stronger pick with 35. 9% revenue growth year-over-year, versus -20. 3% for Occidental Petroleum Corporation (OXY). Devon Energy Corporation (DVN) offers the better valuation at 10. 8x trailing P/E (8. 6x forward), making it the more compelling value choice. Analysts rate Chevron Corporation (CVX) a "Buy" — based on 53 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HP or XOM or CVX or OXY or DVN?
On trailing P/E, Devon Energy Corporation (DVN) is the cheapest at 10.
8x versus Occidental Petroleum Corporation at 33. 5x. On forward P/E, Devon Energy Corporation is actually cheaper at 8. 6x.
03Which is the better long-term investment — HP or XOM or CVX or OXY or DVN?
Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +164.
6%, compared to +44. 0% for Helmerich & Payne, Inc. (HP). Over 10 years, the gap is even starker: CVX returned +135. 8% versus OXY's -7. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HP or XOM or CVX or OXY or DVN?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus Helmerich & Payne, Inc. 's 0. 87β — meaning HP is approximately -699% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 82% for Helmerich & Payne, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HP or XOM or CVX or OXY or DVN?
By revenue growth (latest reported year), Helmerich & Payne, Inc.
(HP) is pulling ahead at 35. 9% versus -20. 3% for Occidental Petroleum Corporation (OXY). On earnings-per-share growth, the picture is similar: Devon Energy Corporation grew EPS -8. 1% year-over-year, compared to -148. 4% for Helmerich & Payne, Inc.. Over a 3-year CAGR, HP leads at 22. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HP or XOM or CVX or OXY or DVN?
Devon Energy Corporation (DVN) is the more profitable company, earning 15.
4% net margin versus -4. 4% for Helmerich & Payne, Inc. — meaning it keeps 15. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DVN leads at 22. 0% versus 6. 2% for HP. At the gross margin level — before operating expenses — OXY leads at 33. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HP or XOM or CVX or OXY or DVN more undervalued right now?
On forward earnings alone, Devon Energy Corporation (DVN) trades at 8.
6x forward P/E versus 15. 0x for Chevron Corporation — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DVN: 18. 6% to $53. 78.
08Which pays a better dividend — HP or XOM or CVX or OXY or DVN?
All stocks in this comparison pay dividends.
Chevron Corporation (CVX) offers the highest yield at 3. 8%, versus 2. 2% for Devon Energy Corporation (DVN).
09Is HP or XOM or CVX or OXY or DVN better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +105. 0% 10Y return). Both have compounded well over 10 years (XOM: +105. 0%, HP: -3. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HP and XOM and CVX and OXY and DVN?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: HP is a small-cap high-growth stock; XOM is a large-cap quality compounder stock; CVX is a large-cap income-oriented stock; OXY is a mid-cap quality compounder stock; DVN is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.